TNF and hypercalcemia disease: PTHrP is expressed in 60% of invasive breast tumors [15], suggesting that substantial proportion of hypercalcemia present in breast cancer patients with extensive bone metastasis, often recognized as LOH, is caused by multiple humoral factors including PTHrP, TNFα, and interleukins.